{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:10:47Z","timestamp":1762506647718},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T00:00:00Z","timestamp":1442880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138091","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T01:06:27Z","timestamp":1442970387000},"page":"e0138091","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?"],"prefix":"10.1371","volume":"10","author":[{"given":"Audrey","family":"Coilly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Dumortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Botta-Fridlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Latournerie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges-Philippe","family":"Pageaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Giostra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa Maria","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Guillaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Lebray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Radenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Catherine","family":"Saouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvon","family":"Calmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Alric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryline","family":"Debette-Gratien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"De Ledinghen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Duvoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Duclos-Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,9,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2012.10.016","article-title":"Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes","volume":"58","author":"P Burra","year":"2013","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"ref3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/liv.12406","article-title":"Management of HCV transplant patients with triple therapy","volume":"34","author":"A Coilly","year":"2014","journal-title":"Liver Int"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/hep.25976","article-title":"A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation","volume":"57","author":"GT Everson","year":"2013","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/lt.21635","article-title":"Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis","volume":"14","author":"B Roche","year":"2008","journal-title":"Liver Transpl"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2008.05.002","article-title":"Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin","volume":"49","author":"M Berenguer","year":"2008","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1053\/j.gastro.2012.02.013","article-title":"Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus","volume":"142","author":"ASt Barritt","year":"2012","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.24443","article-title":"Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus","volume":"54","author":"V Garg","year":"2011","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hep.25831","article-title":"Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers","volume":"56","author":"E Hulskotte","year":"2012","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1128\/AAC.01151-12","article-title":"Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence","volume":"56","author":"A Coilly","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2013.08.018","article-title":"Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience","volume":"60","author":"A Coilly","year":"2014","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1665-2681(19)31252-9","article-title":"Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience","volume":"13","author":"N Faisal","year":"2014","journal-title":"Ann Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2014.04.037","article-title":"A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy","volume":"61","author":"JR Burton Jr","year":"2014","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/lt.23669","article-title":"Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation","volume":"19","author":"S Pungpapong","year":"2013","journal-title":"Liver Transpl"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-0033-1356345","article-title":"Treatment of recurrent genotype 1 hepatitis C post-liver transplantation: single center experience with telaprevir-based triple therapy","volume":"52","author":"CR Werner","year":"2014","journal-title":"Z Gastroenterol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1099\/0022-1317-82-5-1001","article-title":"Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns","volume":"82","author":"Y Morice","year":"2001","journal-title":"J Gen Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1600-6143.2011.03608.x","article-title":"Fibrosing cholestatic hepatitis in HIV\/HCV co-infected transplant patients-usefulness of early markers after liver transplantation","volume":"11","author":"TM Antonini","year":"2011","journal-title":"Am J Transplant"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"DW Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1478-3231.2012.02856.x","article-title":"Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver","volume":"32","author":"V Leroy","year":"2012","journal-title":"Liver Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/lt.23554","article-title":"Interleukin-28B polymorphism in hepatitis C and liver transplantation","volume":"19","author":"A Duarte-Rojo","year":"2013","journal-title":"Liver Transpl"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"S559","DOI":"10.1016\/S0168-8278(12)61430-5","article-title":"A randomized trial comparing ribavirin dose reduction versus erythropoietin for anemia management in previously untreated patients with chronic hepatitis C receiving bocepreir plus peginterferon\/ribavirin","volume":"56","author":"FF Poordad","year":"2012","journal-title":"Journal of Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/j.gastro.2005.06.031","article-title":"Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins","volume":"129","author":"M Nakagawa","year":"2005","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.26602","article-title":"Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir","volume":"59","author":"S Mauss","year":"2014","journal-title":"Hepatology"},{"key":"ref24","article-title":"Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis","author":"R Maan","year":"2014","journal-title":"J Hepatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1053\/j.gastro.2013.10.012","article-title":"Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy","volume":"146","author":"NH Afdhal","year":"2014","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"ref26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/liv.12423","article-title":"HCV direct-acting antiviral agents: the best interferon-free combinations","volume":"34","author":"R Schinazi","year":"2014","journal-title":"Liver Int"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2014.10.001","article-title":"Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation","volume":"148","author":"M Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"ref28","article-title":"Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant","author":"S Pungpapong","year":"2015","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients with Advanced Liver Disease","volume":"149","author":"M Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nrgastro.2013.106","article-title":"Drug-drug interactions during antiviral therapy for chronic hepatitis C","volume":"10","author":"JJ Kiser","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","article-title":"An interferon-free antiviral regimen for HCV after liver transplantation","volume":"371","author":"PY Kwo","year":"2014","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"ref32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/liv.12728","article-title":"Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals","volume":"35","author":"A Coilly","year":"2015","journal-title":"Liver Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:32:31Z","timestamp":1589027551000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138091"}},"subtitle":[],"editor":[{"given":"Ming-Lung","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,22]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138091","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,22]]}}}